MDX Meldex

    RNS Number : 7288B
  Meldex International PLC
  20 August 2008
   

    
 For Immediate Release  20 August 2008


    Meldex International Plc


 TR - 1:  NOTIFICATION OF MAJOR INTERESTS IN SHARES

    1.    Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

    Meldex International Plc

    2.    Reason for the notification (please tick the appropriate box or boxes):

 An acquisition or disposal of voting rights       
                                                   
 An event changing the breakdown of voting rights  

    3.    Full name of person(s) subject to the notification obligation:

    Barclays PLC

    4.    Full name of shareholder(s) (if different from 3.)

    n/a

    5.    Date of the transaction and date on which the threshold is crossed or reached:

    August 18, 2008 

    6.    Date on which issuer notified:

    August 19, 2008

    7.    Threshold(s) that is/are crossed or reached:

    8% to 7%

    
8.    Notified details:


 A: Voting rights attached to shares

 Class/type of shares        Situation previous to the Triggering    Resulting situation after the triggering transaction
    if possible using                                 transaction
        the ISIN CODE
                           Number of Shares      Number of Voting  Number of shares    Number of voting       % of voting
                                                           Rights                                rights            rights
                                                                                     Direct    Indirect  Direct  Indirect
         GB0032681628            17,254,723            17,254,723        17,255,023       0  17,225,023    0.00      7.66

 Total (A+B)

 Number of voting rights  % of voting rights
              17,225,023                7.66

    9.    Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if
applicable

    Barclays Stockbrokers Ltd

    Proxy Voting:

    10.    Name of the proxy holder:

    n/a

    11.     Number of voting rights proxy holder will cease to hold:

    n/a

    12.     Date on which proxy holder will cease to hold voting rights:

    n/a


    For further information: 

 Meldex International Plc  + 44 (0) 20 7098 9880 
  Richard Trevillion, CEO                        
        Steve Martin, CDO
         Hiral Patel, CFO
                                                 
  Buchanan Communications   + 44 (0) 20 7466 5000
    Rebecca Skye Dietrich                        
               Mark Court


    About Meldex International Plc

    Meldex International plc is an innovative specialty pharmaceutical and OTC product Company. Listed on London's AIM in May 2003, the
Company has over 80 patents granted or in application within 24 patent families and has product development agreements and strategic
alliances with several global healthcare companies. Meldex has acquired sales and marketing resources within Europe and the US as a launch
mechanism for its own pharmaceutical products. Meldex acquired the Melbrosin business in June 2007 for a consideration of up to EUR35m,
Melbrosin's focus is on consumer over the counter health care products based on substances of natural and plant origin, which are developed
into consumer orientated brands then scaled, produced and distributed by Melbrosin. The Melbrosin complements the prescription
pharmaceutical sales and marketing business created and expanded in 2006. 

    The business continues to develop innovative delivery mechanisms enhancing both its own product range and those of selected partners
using its proprietary XGEL* polymer technology. For further information please go to www.meldexinternational.com



This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
HOLPMMBTMMATBMP

Meldex (LSE:MDX)
Historical Stock Chart
From Jun 2024 to Jul 2024

Meldex (LSE:MDX)
Historical Stock Chart
From Jul 2023 to Jul 2024